Key Takeaways
- LGT Capital Partners added to Broadcom and Netflix and opened a new Boston Scientific stake. All three now trade 40% or more below their 52-week highs.
- Analysts raised their Broadcom targets and estimates over the past year and cut their Netflix and Boston Scientific targets hard.
- Broadcom is the best buy of the three, but its Anthropic backstops add up to about $72 billion of maximum exposure.
LGT Capital Partners, an investment manager privately owned by Liechtenstein’s princely family, reported $1.97 billion of US-listed stocks across 38 positions in its 13F for the quarter ended June 30, filed Aug. 5. That’s still its latest filing, so the moves are a few months old. Three of its biggest buys sit well off their highs today: Broadcom (AVGO), Netflix (NFLX) and Boston Scientific (BSX).
Wall Street likes only one of them more than it did a year ago.
Broadcom’s Numbers Keep Climbing
LGT raised its Broadcom stake 42% to 175,768 shares, worth $66 million at June 30, or 3.4% of the portfolio. The stock is down 22% since.
AI semiconductor revenue hit $16.7 billion in Broadcom’s fiscal third quarter, up 221%, and management expects about $115 billion of AI revenue in fiscal 2027.
The average price target has climbed by about a third in a year:
It now sits at $533, 82% above the last close, and the fiscal 2027 EPS estimate is up 64% in a year, to $19.43. Yet the stock trades at about 17x forward earnings, against a five-year average of 24x.
TIKR Tracks 133 Analysts Across Broadcom, Netflix and Boston Scientific. How Many Say “Buy”?
See the full breakdown of Buy, Hold, and Sell ratings on all three stocks LGT Capital Partners just bought, along with Wall Street’s revenue and earnings estimates, side by side. Then decide for yourself whether Broadcom deserves to be the pick. More than 500,000 investors use TIKR to research stocks like this one. See the Analyst Ratings on All 3 Stocks
Netflix Is Cheap, and Getting Cheaper
LGT raised its Netflix stake 52% to 736,313 shares, worth $53 million, or 2.7% of the portfolio. The stock is down 11% since June 30.
The average target has fallen from $135 a year ago to $85:
Revenue growth slowed to 11.8% in the third quarter, from 17.2% a year earlier, and Netflix cut its 2026 ad revenue forecast to about $2.7 billion, from about $3 billion. Analysts have trimmed their 2027 EPS estimate 4.3% in a year, to $3.77.
Netflix trades at about 18x forward earnings, against a five-year average of 33x, and Bill Ackman calls it “an incredibly cheap stock.” He’s right about the multiple. But a cheap stock can stay cheap while estimates keep falling.
Boston Scientific’s Recovery Starts in 2028
Boston Scientific was the new position: 915,966 shares, worth $39 million, or 2.0% of the portfolio. The stock is up 0.2% since June 30, but the business has gone backward.
A cyberattack on Aug. 25 disrupted operations, and on Oct. 28 Boston Scientific cut its 2026 outlook for the third time this year. It now expects fourth-quarter revenue to fall 1% to 3%. Electrophysiology sales also fell 5% in the third quarter as pulsed field ablation rivals took share. CEO Mike Mahoney expects 2027 to be the bottom, with growth returning in 2028.
Analysts have cut their average target from $126 a year ago to $50:
That’s 16% upside, the least of the three. At about 14x forward earnings against a five-year average of 26x, the stock is priced for the slow stretch management describes.
Broadcom Is the One I’d Buy
Broadcom is the only one where analysts are raising both targets and estimates, and it still trades well below its usual multiple.
The risk is Anthropic. Broadcom backstops up to about $29 billion of AI rack leases from June and could owe up to about $43 billion more on October’s $63 billion deal. That’s about $72 billion of maximum exposure, against $24.0 billion of cash at Aug. 2. Anthropic’s amended S-1 also lists about $161 billion of equipment lease obligations tied to Broadcom.
Still, 82% upside on rising estimates leaves Broadcom the most room for error. Its December report will show whether management holds the $115 billion AI outlook. LGT’s next 13F, due by Nov. 16, will show whether it held all three as of Sept. 30.
So what is Broadcom stock actually worth?
TIKR lets you forecast the future price of any stock in less than a minute. Just enter a few assumptions into TIKR’s valuation model and see what Broadcom could be worth. Start from Wall Street consensus estimates, or adjust the inputs to reflect your own view of the business. It’s free to use.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!
